TY  - GEN
AU  - Bartiromo,Marilù
AU  - Borchi,Beatrice
AU  - Botta,Annarita
AU  - Bagalà,Alfredo
AU  - Lugli,Gianmarco
AU  - Tilli,Marta
AU  - Cavallo,Annalisa
AU  - Xhaferi,Brunilda
AU  - Cutruzzulà,Roberta
AU  - Vaglio,Augusto
AU  - Bresci,Silvia
AU  - Larti,Aida
AU  - Bartoloni,Alessandro
AU  - Cirami,Calogero
TI  - Threatening drug-drug interaction in a kidney transplant patient with coronavirus disease 2019 (COVID-19)
SN  - 1399-3062
PY  - 2020///0813
KW  - Adult
KW  - Antiviral Agents
KW  - adverse effects
KW  - Betacoronavirus
KW  - C-Reactive Protein
KW  - immunology
KW  - COVID-19
KW  - Ciliopathies
KW  - complications
KW  - Cobicistat
KW  - therapeutic use
KW  - Common Cold
KW  - etiology
KW  - Coronavirus Infections
KW  - Cough
KW  - Cytochrome P-450 CYP3A Inhibitors
KW  - Darunavir
KW  - Deprescriptions
KW  - Drug Combinations
KW  - Drug Interactions
KW  - Enzyme Inhibitors
KW  - Fatigue
KW  - Female
KW  - Glucocorticoids
KW  - Graft Rejection
KW  - prevention & control
KW  - Humans
KW  - Hydroxychloroquine
KW  - Immunocompromised Host
KW  - Immunosuppressive Agents
KW  - Interleukin-10
KW  - Interleukin-1beta
KW  - Interleukin-6
KW  - Interleukin-8
KW  - Kidney Diseases, Cystic
KW  - Kidney Failure, Chronic
KW  - Kidney Transplantation
KW  - Leber Congenital Amaurosis
KW  - Lopinavir
KW  - Methylprednisolone
KW  - Optic Atrophies, Hereditary
KW  - Pandemics
KW  - Pneumonia, Viral
KW  - Ritonavir
KW  - SARS-CoV-2
KW  - Severity of Illness Index
KW  - Tacrolimus
KW  - COVID-19 Drug Treatment
N1  - Publication Type: Case Reports; Journal Article
UR  - https://doi.org/10.1111/tid.13286
ER  -